Concepedia

Sarah Dudley

SD

Statistics

Publications

4

Citations

804

H-Index

4

Active since

2012

Affiliations

Synairgen (United Kingdom)(Current)

University of Southampton

NIHR Southampton Respiratory Biomedical Research Unit

University Hospital Southampton NHS Foundation Trust

Gartnavel General Hospital

Sarah Dudley is an author at Synairgen (United Kingdom) specializing in immunology, pharmacy, and antiviral therapy.

Publications per year

2012–2024

4

Publications

4

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Phillip Monk, Richard Marsden, Victoria Tear et al. · The Lancet Respiratory Medicine · 2020 · 455 citations · Full text

, , +10

The Effect of Inhaled IFN-β on Worsening of Asthma Symptoms Caused by Viral Infections. A Randomized Trial

Ratko Djukanović, Tim Harrison, Sebastian L. Johnston et al. · American Journal of Respiratory and Critical Care Medicine · 2014 · 269 citations · Full text

, , +17

Barrier responses of human bronchial epithelial cells to grass pollen exposure

Cornelia Blume, Emily J. Swindle, Patrick Dennison et al. · European Respiratory Journal · 2012 · 69 citations · Full text

, , +16

Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD

Phillip Monk, J. Brookes, Victoria Tear et al. · Respiratory Research · 2024 · 11 citations · Full text

, , +17

1–4 of 4